Toni Dezomits had to change her ovarian cancer treatment plan due to a shortage of chemotherapy drugs Toni Dezomits, a 55-year-old retired law enforcement officer, is battling a recurrence of her stage 4 ovarian cancer. She had already undergone several rounds of chemotherapy when her doctor told her he had more bad news. Just a day before her third round of treatment last month, Ms. Dezomits was told there was a nationwide shortage of the generic chemotherapy drug, carboplatin, one of three drugs she was due to receive. Forced to…
Read MoreTag: drug
Obesity Drug Stocks: Time to Buy Manufacturers of Ozempic, Mounjaro, Others?
The demand for drug therapies for obesity is on the rise. New drugs with efficacy rivaling bariatric surgery, with only minor tolerability issues, have replaced older drugs burdened with significant cardiovascular side effects and mediocre efficacy. The approval of Novo Nordisks’ NVO GLP-1 agonist Wegovy in 2021 led to increased demand for the active ingredient semaglutide in various forms, including the diabetes drug Ozempic. Mounjaro, the Eli Lillys LLY-approved diabetes drug, is poised to generate even stronger weight-loss results and will launch as an obesity treatment around the end of…
Read MoreEvidence shows the immunotherapy drug Opdivo is safe and effective against Hodgkin’s lymphoma
Nivolumab outperformed the drug brentuximab vedotin (Adcetris), extending progression-free survival by 94% to one year versus 86%. Photo by Erubiel Flores/Pixabay The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard of care, new clinical trial results show. Nivolumab outperformed the drug brentuximab vedotin (Adcetris), extending progression-free survival by 94% to one year versus 86%. Advertising Nivolumab also produced significantly fewer side effects than brentuximab vedotin, which was the first new…
Read MoreOzempic is taking China by storm. Drug makers are scrambling to ramp up supplies | CNN business
Hong Kong Cnn Ozempic, originally a drug to treat diabetes, is in high demand around the world with celebrities and social media users touting it as a weight loss wonder drug, despite some concerns from medical experts. Now the frenzy is sweeping China, where being skinny is a prevalent beauty standard, leading to shortages in the country. Chinese social media apps, such as Douyin and Xiaohongshu, have been flooded with posts from users boasting that they have easily lost 10 or more pounds in a month with just a few…
Read MoreMerck sues law that allows Medicare to negotiate with drug makers
Pharmaceutical company Merck sued the government Tuesday over a federal law that allows Medicare to negotiate prices directly with drug makers for the first time. The Merck lawsuit, filed in federal court in Washington, is the drug industry’s most significant move yet to thwart a major health care policy change, which takes effect in 2026. Democrats pushed through the Medicare negotiating program last summer as a provision of the Inflation Reduction Act, framing it as a way to lower drug prices. Only certain drugs will be subject to negotiation with…
Read More